Reported Earlier, Lycia Therapeutics Prices Upsized Initial Public Offering Of 17.64M Shares At $18.00 Each For Expected $317.5M Gross Proceed

Loading news article.

Reported Earlier, Lycia Therapeutics Prices Upsized Initial Public Offering Of 17.64M Shares At $18.00 Each For Expected $317.5M Gross Proceed | WAPE

Article summary